Heranba Industries Ltd
NSE: HERANBA BSE: 543266
Incorporated in 1994, Heranba Industries Ltd is engaged in the manufacturing of a diverse range of agrochemicals such as insecticides, herbicides, fungicides and public health products for pest control. [1]
₹196
52W: ₹155 — ₹404
PE 13.5 · Book ₹244 · -20% vs bookMarket Cap₹786 Cr
Stock P/E13.5Price to Earnings
ROCE9.1%Return on Capital
ROE5.93%Return on Equity
Div. Yield0.51%Face Value ₹10
Strengths
- +Stock is trading at 0.82 times its book value
- +Company's working capital requirements have reduced from 69.3 days to 25.9 days
Weaknesses
- −The company has delivered a poor sales growth of 9.47% over past five years.
- −Company has a low return on equity of 9.13% over last 3 years.
- −Earnings include an other income of Rs.65.0 Cr.
- −Dividend payout has been low at 6.50% of profits over last 3 years
Shareholding Pattern
Promoters74.95%
FIIs0.07%
DIIs0.28%
Public24.7%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 74.95% | 74.95% | 74.95% | 74.95% | 74.95% | 74.95% | 74.95% | 74.95% |
| FIIs | 0% | 0.4%▲0.4 | 0.42%▲0.0 | 0.1%▼0.3 | 0.05%▼0.1 | 0.06%▲0.0 | 0.08%▲0.0 | 0.07%▼0.0 |
| DIIs | 0% | 0% | 0.21%▲0.2 | 0.21% | 0.28%▲0.1 | 0.28% | 0.28% | 0.28% |
| Public | 25.06% | 24.67%▼0.4 | 24.44%▼0.2 | 24.75%▲0.3 | 24.73%▼0.0 | 24.74%▲0.0 | 24.71%▼0.0 | 24.7%▼0.0 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 429.51 | 301.7 | 261.29 | 304.35 | 457.64 | 338.49 | 395.42 | 489.84 | 605.73 | 306.55 |
| Expenses | 382.62 | 273.41 | 241.69 | 256.13 | 411.34 | 348 | 397.21 | 469.55 | 561.02 | 291.75 |
| Operating Profit | 46.89 | 28.29 | 19.6 | 48.22 | 46.3 | -9.51 | -1.79 | 20.29 | 44.71 | 14.8 |
| OPM % | 10.92% | 9.38% | 7.5% | 15.84% | 10.12% | -2.81% | -0.45% | 4.14% | 7.38% | 4.83% |
| Net Profit | 32.51 | 19.22 | 13.11 | 34.45 | 33.96 | -9.12 | -5.28 | 22.02 | 32.04 | 9.32 |
| EPS ₹ | 8.12 | 4.8 | 3.28 | 8.61 | 8.49 | -2.28 | -1.32 | 5.5 | 8.01 | 2.33 |
AI Insights
Revenue Trend
TTM revenue at ₹1,798Cr, up 20.2% YoY. OPM at 4%.
Debt Position
Borrowings at ₹409Cr. Debt-to-equity ratio: 0.44x. Healthy balance sheet.
Capex Cycle
CWIP at ₹1Cr (0% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 0.28% (-0.57pp change). FIIs: 0.07% (+0.07pp change). Promoters hold 74.95%.
Margin & Efficiency
ROCE improving from 0% (Mar 2016) to 9% (Mar 2025). Working capital days: 26.
Valuation
PE 13.5x with 9.1% ROCE. Price is -20% above book value of ₹244. Dividend yield: 0.51%.
Recent Announcements
- Pendency Of Litigation(S)/Dispute(S) Or The Outcome Impacting The Company. 13 May - NCLT dismissed insolvency application against HOPL on May 12, 2026; no CIRP initiated.
- Announcement under Regulation 30 (LODR)-Updates on Acquisition 7 May - Heranba converted ₹450 crore ICDs into OFCDs of subsidiary HOPL on May 7, 2026.
- Announcement under Regulation 30 (LODR)-Acquisition 27 Apr - Heranba converts ₹450 crore ICDs into OFCDs of subsidiary HOPL on April 27, 2026.
- Board Meeting Outcome for Outcome Of Board Meeting 27 Apr - Board approved conversion of ₹450 crore ICDs into 10-year 1% OFCDs for HOPL on April 27, 2026.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 22 Apr - Enclosed herewith Newspaper Publication in respect of Postal Ballot Notice.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse